85% Opioid Settlement Fund Share
The Opioid Settlement Fund holds 85% of Connecticut’s opioid settlement funds.[1]
With limited exceptions,[2] this share must be spent on abatement uses consistent with the national settlement agreement’s (non-exhaustive) , which includes prevention, harm reduction, treatment, recovery, and other strategies.[3]
Subcommittees and stakeholders recommend, Connecticut Opioid Settlement Advisory Committee (OSAC) decides, Department of Mental Health and Addiction Services administers and oversees. The ,[4] which ultimately decides specific expenditures for this share,[5] consults recommendations from — including Yale’s Connecticut Opioid REsponse (CORE) Initiative[6] — before approving allocations of the Opioid Settlement Fund.[7] The (DMHA) then disburses funds and oversees their uses.[8]
Yes, supplantation is prohibited. State law explicitly states that the Opioid Settlement Fund’s expenditures “shall be supplemental to, and shall not supplant or take the place of, any other funds … that would otherwise have been expended for such purposes.”[9] Connecticut goes a step further by requiring the Secretary of the Office of Policy and Management to submit a letter each year to the verifying that funds appropriated from the Opioid Settlement Fund in that fiscal year’s budget for “substance use disorder abatement infrastructure, programs, services, supports, and resources for prevention, treatment, recovery and harm reduction” are not less than the funds appropriated and allocated from the previous fiscal year’s budget for those purposes.[10]